Lixte Biotechnology Holdings- Warrants (01/01/2025) Overview
Lixte Biotechnology Holdings- Warrants (01/01/2025) Discounted Cash Flow
DCF Analysis for LIXTW.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.09
Current Fair Value
$0.09
↑ 315.4% Upside
Undervalued by 315.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison